The Health Equity Heat Map developed by the American College of Cardiology (ACC) is a population health map that leverages location-based metrics to examine the demographics of local communities ...

Among patients with severe left ventricular (LV) dysfunction and severe coronary heart disease undergoing complex PCI, elective LV unloading with a microaxial flow pump did not reduce the risk of ...

July 4th, 1976: America was celebrating its 200th birthday – a free nation, indivisible and strong. On that same morning, thousands of miles away, a small, awkward adolescent girl stood quietly in her ...

It really has been an incredible few days. From the very start of Day 1, ACC.26 delivered. We opened with Late-Breaking Clinical Trial results from the HI-PEITHO, CHAMPION-AF and STEMI-Door to Unload ...

When compared with angiography-guided PCI, IVUS-guided PCI was found to be not superior in patients with complex coronary arteries according to results from the IVUS-CHIP trial or in patients with ...

A noninvasive device used to monitor early fluid accumulation in the lungs of patients with heart failure with preserved ejection fraction (HFpEF) substantially reduced HF hospitalizations and ...

Older patients with coronary artery disease (CAD) for whom PCI was deferred until after TAVI had similar outcomes as those for whom it was not deferred, according to findings from the PRO-TAVI study ...

Transcatheter tricuspid edge-to-edge repair (T-TEER) in addition to standard-of-care medical therapy reduced the risk of death, myocardial infarction (MI), stroke and hospitalization for heart failure ...

Mavacamten, a first-in-class drug, was associated with a significant improvement in left ventricular outflow tract (LVOT) gradient compared to placebo in adolescent patients with obstructive ...

US and international guidelines advocate for the achievement of very low levels of LDL-C, particularly for individuals at highest risk. The concerns about stroke and cognitive issues with very low LDL ...

The American College of Cardiology is pleased to offer fellows in training, medical residents, doctoral or medical students and Cardiovascular Team students (nurses, pharmacists, PAs, and ...

Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options ...